openPR Logo
Press release

Lawsuit filed for Investors in shares of PharmaCielo Ltd. (OTC: PCLOF)

03-14-2020 04:21 AM CET | Politics, Law & Society

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in PharmaCielo Ltd. (OTC: PCLOF) shares over alleged securities laws violations.

A lawsuit was filed on behalf of investors in PharmaCielo Ltd. (OTC: PCLOF) shares over alleged securities laws violations.

An investor, who purchased shares of PharmaCielo Ltd. (OTC: PCLOF), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by PharmaCielo Ltd..

Investors who purchased shares of PharmaCielo Ltd. (OTC: PCLOF) have certain options and for certain investors are short and strict deadlines running. Deadline: May 5, 2020. OTC: PCLOF investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On March 2, 2020, a report was published alleging that PharmaCielo was "nothing more than the latest self-enrichment scheme drummed up by its co-founder Anthony Wile, who had been charged by the SEC over allegations of securities fraud, stock promotion and market manipulation in the past." Hindenburg also visited PharmaCielo's purported greenhouse facilities in Colombia and found that the site is "nothing more than an empty field covered in weeds."

Shares of PharmaCielo Ltd. (OTC: PCLOF) declined from $8.95 per share in March 2019 to as low as $0.46 per share on March 12, 2020.

The plaintiff claims that between June 21, 2019 and March 2, 2020, the defendants made false and/or misleading statements and/or failed to disclose that PharmaCielo engaged in an undisclosed related party transactions with General Extract LLC, that PharmaCielo engaged in misleading transactions and loans with General Extract LLC and XPhyto Therapeutics Corp., that PharmaCielo's Research Technology and Processing Centre was never on-schedule and is delayed, that the Rionegro facility is located on a floodplain and contaminated with mold and pesticides from its previous tenants, that PharmaCielo's Cauca Department land has never been utilized by the Company and is idle, and that as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Those who purchased shares of PharmaCielo Ltd. (OTC: PCLOF) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors in shares of PharmaCielo Ltd. (OTC: PCLOF) here

News-ID: 1967222 • Views: 630

More Releases from Shareholders Foundation

Ormat Technologies, Inc. (NYSE: ORA) Investor Noticet: Investigation over potent …
An investigation on behalf of investors in shares of Ormat Technologies, Inc. (NYSE: ORA) was announced over potential breaches of fiduciary duties by certain officers and directors at Ormat Technologies, Inc. Investors who purchased shares of Ormat Technologies, Inc. (NYSE: ORA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Ormat Technologies directors breached their
Investigation announced for Investors in Knoll, Inc. (NYSEL KNL) shares over Tak …
An investigation was announced concerning whether the takeover of Knoll, Inc. is unfair to NYSEL KNL stockholders. Investors who purchased shares of Knoll, Inc. (NYSEL KNL) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain officers and directors of Knoll, Inc. breached their fiduciary duties owed to NYSEL KNL investors in connection with the proposed
Investigation announced for Long-Term Investors in shares of Plains GP Holdings, …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Plains GP Holdings, L.P. Investors who purchased shares of Plains GP Holdings, L.P. (NASDAQ: PAGP) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Plains GP Holdings directors breached their fiduciary duties and caused damage to the company and
Investigation announced for Long-Term Investors in shares of iRhythm Technologie …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of iRhythm Technologies, Inc.. Investors who are current long term investors in iRhythm Technologies, Inc. (NASDAQ: IRTC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: IRTC stocks follows a lawsuit filed against iRhythm

All 5 Releases


More Releases for PharmaCielo

Investigation for Long-Term Investors in shares of PharmaCielo Ltd. (OTC: PCLOF) …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of PharmaCielo Ltd.. Investors who are current long term investors in PharmaCielo Ltd. (OTC: PCLOF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in OTC: PCLOF stocks follows a lawsuit filed against PharmaCielo Ltd. over
Deadline in Lawsuit on May 5th coming up for Investors in PharmaCielo Ltd. (OTC: …
A deadline is coming up on May 5, 2020 in the lawsuit filed for certain investors of PharmaCielo Ltd. (OTC: PCLOF) over alleged securities laws violations by PharmaCielo Ltd. Investors who purchased shares of PharmaCielo Ltd. (OTC: PCLOF) have certain options and there are strict and short deadlines running. Deadline: HHHHH. OTC: PCLOF stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the complaint filed